First Tracks Biotherapeutics (HAM:B43) Beneish M-Score


HAM:B43 First Tracks Biotherapeutics Inc HAM:B43
20 GF Score
Price €32.00
! 3 Warning Signs
View Full Analysis

What is First Tracks Biotherapeutics Beneish M-Score?

First Tracks Biotherapeutics does not have enough data to calculate Beneish M-Score.

First Tracks Biotherapeutics Beneish M-Score Historical Data

* Premium members only.

The historical data trend for First Tracks Biotherapeutics's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

First Tracks Biotherapeutics Beneish M-Score Chart

First Tracks Biotherapeutics Annual Data
Trend Dec23 Dec24
Beneish M-Score
0.00 0.00

First Tracks Biotherapeutics Semi-Annual Data
Dec23 Dec24
Beneish M-Score 0.00 0.00

HAM:B43 vs ALT, RGNX, MDXG: Beneish M-Score Comparison

For the Biotechnology subindustry, First Tracks Biotherapeutics's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

First Tracks Biotherapeutics Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, First Tracks Biotherapeutics's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where First Tracks Biotherapeutics's Beneish M-Score falls into.


HAM:B43
20GF Score
First Tracks Biotherapeutics Inc HAM:B43
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

First Tracks Biotherapeutics Business Description

Other Exchanges TRAX:USA
Address 10770 Wateridge Circle, Suite 210, San Diego, CA, USA, 92121
First Tracks Biotherapeutics Inc is a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases. Its clinical-stage pipeline includes rosnilimab, a selective pathogenic T cell depleter, for which it completed a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA), ANB033, a CD122 antagonist, in a Phase 1b trial for celiac disease (CeD) and eosinophilic esophagitis (EoE), and ANB101, a BDCA2 modulator, in a Phase 1a trial. The company operates in one reportable segment focused on research and development activities to deliver immunology therapeutics for autoimmune and inflammatory diseases.
20GF Score

Get the complete analysis for HAM:B43

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€32.00
Price